Low-Dose Hydrocortisone Improves Cognitive Function in Women with HIV

Women living with HIV often experience heightened stress levels, which can negatively impact cognitive functions like verbal learning, memory, and attention. Emerging research indicates that low-dose hydrocortisone may offer a targeted intervention to improve these cognitive abilities, even after a single dose or with consistent, short-term use.

The Link Between HIV, Stress, and Cognitive Function

Research highlights a strong correlation between HIV infection in women and increased levels of stress, trauma, and mood disorders such as anxiety and posttraumatic stress disorder (PTSD). These factors are known to significantly affect cognitive performance, particularly in areas related to learning, and memory. Leah Rubin, PhD, MPH, MA, a professor of neurology, psychiatry and behavioral sciences and epidemiology at Johns Hopkins University, emphasized this connection, stating that high levels of trauma and chronic stress are “robust predictors of cognitive function” in women with HIV. Healio

How Hydrocortisone Offers a Potential Solution

Low-dose hydrocortisone (LDH) has shown promise in enhancing cognitive functions in individuals with conditions like PTSD and, previously, in men with HIV. Recent studies have now demonstrated its positive effects in women with HIV. A study presented at the Conference on Retroviruses and Opportunistic Infections (CROI) 2026 revealed that LDH improved verbal learning, memory, and attention in virally suppressed women with HIV. Healio

Study Details and Findings

Research, including a double-blind, placebo-controlled, cross-over study, has investigated the cognitive effects of LDH in HIV-infected women. AIDS Findings indicate that a single low dose of hydrocortisone can enhance aspects of learning and memory. PMC The benefits were observed both after a single administration and with daily use over a four-week period. Healio

Looking Ahead

These findings suggest that low-dose hydrocortisone could be a valuable therapeutic option for addressing cognitive impairment in women living with HIV. Further research is needed to fully understand the long-term effects and optimal dosage regimens. However, the current evidence provides a hopeful avenue for improving the quality of life for this vulnerable population.

Key Takeaways

• Women with HIV are at increased risk for stress and cognitive dysfunction.
• Low-dose hydrocortisone has demonstrated improvements in verbal learning, memory, and attention in women with HIV.
• Benefits were observed with both single-dose and four-week daily treatment.